BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ. 2003;326:737. [PMID: 12676842 DOI: 10.1136/bmj.326.7392.737] [Cited by in Crossref: 215] [Cited by in F6Publishing: 192] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Mégraud F, Xiao SD, Sugano K, Nyrén O. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol. 2005;100:2100-2115. [PMID: 16128957 DOI: 10.1111/j.1572-0241.2005.41688.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 130] [Article Influence: 8.1] [Reference Citation Analysis]
2 . UEG Week 2016 Oral Presentations. United European Gastroenterology Journal 2016;4:A1-A156. [DOI: 10.1177/2050640616663688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Isomoto H, Kanazawa Y, Kohno S. Expression of Interleukin 8 Messenger Ribonucleic Acid in Esophageal Mucosa of Patients with Gastroesophageal Reflux Disease in Terms of Helicobacter pylori Status: Response. Am J Gastroenterology 2004;99:2501-2. [DOI: 10.1111/j.1572-0241.2004.41389_4.x] [Reference Citation Analysis]
4 Minatsuki C, Yamamichi N, Shimamoto T, Kakimoto H, Takahashi Y, Fujishiro M, Sakaguchi Y, Nakayama C, Konno-Shimizu M, Matsuda R, Mochizuki S, Asada-Hirayama I, Tsuji Y, Kodashima S, Ono S, Niimi K, Mitsushima T, Koike K. Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS One. 2013;8:e69891. [PMID: 23922844 DOI: 10.1371/journal.pone.0069891] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
5 Frissora CL, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep. 2005;7:264-271. [PMID: 16042909 DOI: 10.1007/s11894-005-0018-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
6 Massey BT. The implications of Helicobacter pylori infection for gastroesophageal reflux disease: Studies presented at Digestive Disease Week 2003. Curr Gastroenterol Rep 2004;6:191-5. [DOI: 10.1007/s11894-004-0005-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Schwizer W, Menne D, Schütze K, Vieth M, Goergens R, Malfertheiner P, Leodolter A, Fried M, Fox MR. The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study. United European Gastroenterol J. 2013;1:226-235. [PMID: 24917966 DOI: 10.1177/2050640613484020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
8 Coleman HG, Xie SH, Lagergren J. The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology. 2018;154:390-405. [PMID: 28780073 DOI: 10.1053/j.gastro.2017.07.046] [Cited by in Crossref: 183] [Cited by in F6Publishing: 171] [Article Influence: 36.6] [Reference Citation Analysis]
9 Enomoto S, Oka M, Ohata H, Mukoubayashi C, Watanabe M, Moribata K, Muraki Y, Shingaki N, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Tamai H, Fujishiro M, Mohara O, Ichinose M. Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage. World J Gastrointest Endosc 2011; 3(4): 71-77 [PMID: 21603035 DOI: 10.4253/wjge.v3.i4.71] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
10 Richter JE, Rubenstein JH. Presentation and Epidemiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:267-276. [PMID: 28780072 DOI: 10.1053/j.gastro.2017.07.045] [Cited by in Crossref: 125] [Cited by in F6Publishing: 82] [Article Influence: 25.0] [Reference Citation Analysis]
11 Sonnenberg A. Review article: historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther. 2013;38:329-342. [PMID: 23786250 DOI: 10.1111/apt.12380] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
12 Kuipers EJ, Malfertheiner P. Helicobacter pylori and Nonmalignant Diseases. Helicobacter 2004;9:29-34. [DOI: 10.1111/j.1083-4389.2004.00247.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
13 Atug O, Giral A, Kalayci C, Dolar E, Isitan F, Oguz D, Ovunc O, Ozgur O, Soykan I, Simsek I, Unal S, Yenice N. Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study. Adv Therapy 2008;25:552-66. [DOI: 10.1007/s12325-008-0071-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149:302-17.e1. [PMID: 25957861 DOI: 10.1053/j.gastro.2015.04.053] [Cited by in Crossref: 182] [Cited by in F6Publishing: 175] [Article Influence: 26.0] [Reference Citation Analysis]
15 Jonaitis L, Kiudelis G, Slepavicius P, Kupcinskas L. High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients. World J Gastrointest Pathophysiol 2016; 7(1): 181-185 [PMID: 26909241 DOI: 10.4291/wjgp.v7.i1.181] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Sumi S, Ishimura N, Mikami H, Okimoto E, Tamagawa Y, Mishiro T, Kinoshita Y, Ishihara S. Evaluations of Gastric Acid Pocket Using Novel Vertical 8-Channel pH Monitoring System and Effects of Acid Secretion Inhibitors. J Neurogastroenterol Motil 2021;27:370-6. [PMID: 34210902 DOI: 10.5056/jnm20115] [Reference Citation Analysis]
17 Kulig M, Nocon M, Vieth M, Leodolter A, Jaspersen D, Labenz J, Meyer-sabellek W, Stolte M, Lind T, Malfertheiner P, Willich S. Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. Journal of Clinical Epidemiology 2004;57:580-9. [DOI: 10.1016/j.jclinepi.2003.10.010] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 5.3] [Reference Citation Analysis]
18 Fock KM, Ang TL. Global epidemiology of Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2011;5:123-30. [PMID: 21309677 DOI: 10.1586/egh.10.82] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
19 Abe Y, Koike T, Iijima K, Imatani A, Ishida K, Yuki T, Miyata G, Shimosegawa T. Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori. Case Rep Gastroenterol 2011;5:355-60. [PMID: 21769287 DOI: 10.1159/000329878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Xie T, Cui X, Zheng H, Chen D, He L, Jiang B. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2013;25:1195-205. [PMID: 23839160 DOI: 10.1097/MEG.0b013e328363e2c7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kashyap B, Kaur IR, Garg PK, Das D, Goel S. 'Test and treat' policy in dyspepsia: time for a reappraisal. Trop Doct 2012;42:109-11. [PMID: 22431830 DOI: 10.1258/td.2011.110411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Kawanishi M. Will symptomatic gastroesophageal reflux disease develop into reflux esophagitis? J Gastroenterol 2006;41:440-3. [DOI: 10.1007/s00535-006-1791-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
23 Pandya HB, Agravat HH, Patel JS. Prevalence of Specific Helicobacter PyloricagA, vacA, iceA, ureC Genotypes and its Clinical Relevance in the Patients with Acid-Peptic Diseases. J Clin Diagn Res 2017;11:DC23-6. [PMID: 28969123 DOI: 10.7860/JCDR/2017/27812.10457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Peek RM. Helicobacter pylori and Gastroesophageal Reflux Disease. Curr Treat Options Gastroenterol 2004;7:59-70. [PMID: 14723839 DOI: 10.1007/s11938-004-0026-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
25 Xu SJ, Wang SX, Wang XT, Cai LY, Kong GM. Relationship between gastroesophageal reflux disease and Helicobacter pylori infection. Shijie Huaren Xiaohua Zazhi 2020; 28(2): 65-69 [DOI: 10.11569/wcjd.v28.i2.65] [Reference Citation Analysis]
26 Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013;107:230-236. [PMID: 23129495 DOI: 10.1002/jso.23262] [Cited by in Crossref: 245] [Cited by in F6Publishing: 229] [Article Influence: 24.5] [Reference Citation Analysis]
27 Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808-1825. [PMID: 17608775 DOI: 10.1111/j.1572-0241.2007.01393.x] [Cited by in Crossref: 769] [Cited by in F6Publishing: 682] [Article Influence: 51.3] [Reference Citation Analysis]
28 Pandeya N, Green AC, Whiteman DC; Australian Cancer Study. Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community. Dis Esophagus. 2012;25:573-583. [PMID: 22128757 DOI: 10.1111/j.1442-2050.2011.01287.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
29 Raghunath AS, Hungin APS, Wooff D, Childs S. The effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis: SYSTEMATIC REVIEW: H. PYLORI , DUODENAL ULCERS AND GERD. Alimentary Pharmacology & Therapeutics 2004;20:733-44. [DOI: 10.1111/j.1365-2036.2004.02172.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
30 Ida T, Inamori M, Inoh Y, Fujita K, Hamanaka J, Chiba H, Kusakabe A, Morohashi T, Goto T, Maeda S. Clinical Characteristics of Severe Erosive Esophagitis among Patients with Erosive Esophagitis: A Case-control Study. Intern Med 2017;56:1293-300. [PMID: 28566589 DOI: 10.2169/internalmedicine.56.8058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
31 Gisbert JP, Piqué JM. Indicaciones y consecuencias de la erradicación de Helicobacter pylori en la enfermedad por reflujo gastroesofágico. Medicina Clínica 2005;124:697-709. [DOI: 10.1157/13075094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
32 Armstrong D, Veldhuyzen van Zanten SJO, Barkun AN, Chiba N, Thomson ABR, Smyth S, Sinclair P, Chakraborty B, White RJ; The CADET-HR Study Group1. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care - the CADET-HR Study. Aliment Pharmacol Ther 2005;21:1189-202. [DOI: 10.1111/j.1365-2036.2005.02466.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
33 O'Connor A, O'Morain CA, Ford AC. Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol. 2017;14:230-240. [PMID: 28053340 DOI: 10.1038/nrgastro.2016.195] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 15.4] [Reference Citation Analysis]
34 Singh SP, Ahuja V, Ghoshal UC, Makharia G, Dutta U, Zargar SA, Venkataraman J, Dutta AK, Mukhopadhyay AK, Singh A, Thapa BR, Vaiphei K, Sathiyasekaran M, Sahu MK, Rout N, Abraham P, Dalai PC, Rathi P, Sinha SK, Bhatia S, Patra S, Ghoshal U, Poddar U, Mouli VP, Kate V. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology. Indian J Gastroenterol 2021. [PMID: 34219211 DOI: 10.1007/s12664-021-01186-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Daugule I, Rumba I, Alksnis J, Ejderhamn J. Helicobacter pylori infection among children with gastrointestinal symptoms: a high prevalence of infection among patients with reflux oesophagitis. Acta Paediatr 2007;96:1047-9. [PMID: 17524023 DOI: 10.1111/j.1651-2227.2007.00329.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
36 Nam SY, Choi IJ, Ryu KH, Kim BC, Kim CG, Nam BH. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol. 2010;105:2153-2162. [PMID: 20571493 DOI: 10.1038/ajg.2010.251] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
37 Neto AG, Whitaker A, Pei Z. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma. Semin Oncol. 2016;43:86-96. [PMID: 26970127 DOI: 10.1053/j.seminoncol.2015.09.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
38 Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease--part II. Curr Probl Surg 2005;42:796-862. [PMID: 16344044 DOI: 10.1067/j.cpsurg.2005.08.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Biccas BN, Lemme EMO, Abrahão Jr. LJ, Aguero GC, Alvariz Â, Schechter RB. Maior prevalência de obesidade na doença do refluxo gastroesofagiano erosiva. Arq Gastroenterol 2009;46:15-9. [DOI: 10.1590/s0004-28032009000100008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
40 Richter JE. Gastrooesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2007;21:609-631. [PMID: 17643904 DOI: 10.1016/j.bpg.2007.03.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
41 Pandolfino JE, Howden CW, Kahrilas PJ. H. Pylori and GERD: Is Less More? Am J Gastroenterology 2004;99:1222-5. [DOI: 10.1111/j.1572-0241.2004.40364.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
42 Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43:1-14. [PMID: 24503355 DOI: 10.1016/j.gtc.2013.11.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
43 Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005;129:1756-1780. [PMID: 16285971 DOI: 10.1053/j.gastro.2005.09.020] [Cited by in Crossref: 278] [Cited by in F6Publishing: 216] [Article Influence: 17.4] [Reference Citation Analysis]
44 Koizumi S, Motoyama S, Iijima K. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan. J Gastroenterol 2018;53:827-33. [PMID: 29134330 DOI: 10.1007/s00535-017-1412-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
45 Nam SY. Helicobacter pylori Has an Inverse Relationship With Severity of Reflux Esophagitis. J Neurogastroenterol Motil 2011;17:209-10. [PMID: 21860812 DOI: 10.5056/jnm.2011.17.3.209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Sakamoto Y, Oho K, Toyonaga A, Kumamoto M, Haruta T, Inoue H, Emori K, Tsuruta O, Sata M. Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension. J Gastroenterol Hepatol. 2013;28:1444-1449. [PMID: 23577833 DOI: 10.1111/jgh.12221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
47 Chang CH, Wu CP, Wang JD, Lee SW, Chang CS, Yeh HZ, Ko CW, Lien HC. Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men. PLoS One. 2017;12:e0173230. [PMID: 28264069 DOI: 10.1371/journal.pone.0173230] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
48 Ang TL, Fock KM, Teo EK, Chan YH, Ng TM, Chua TS, Tan JY. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study. J Gastroenterol. 2006;41:647-653. [PMID: 16933001 DOI: 10.1007/s00535-006-1818-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
49 Sifrim D, Zhang X. Pathophysiology of GERD in China: the same factors at a lower scale. Am J Gastroenterol. 2004;99:2094-2097. [PMID: 15554986 DOI: 10.1111/j.1572-0241.2004.41145.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
50 Kang JY. Geographical and ethnic differences in gastro-oesophageal reflux disease: SYSTEMATIC REVIEW: GEOGRAPHICAL AND ETHNIC DIFFERENCES IN GERD. Alimentary Pharmacology & Therapeutics 2004;20:705-17. [DOI: 10.1111/j.1365-2036.2004.02165.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
51 Wang C, Yuan Y, Hunt RH. Helicobacter pylori Infection and Barrett's Esophagus: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2009;104:492-500. [DOI: 10.1038/ajg.2008.37] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
52 Dore MP, Pes GM, Bassotti G, Farina MA, Marras G, Graham DY. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia. Scandinavian Journal of Gastroenterology 2016;51:1281-7. [DOI: 10.1080/00365521.2016.1200137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
53 Fujiwara Y, Higuchi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T. Functional oesophageal epithelial defense against acid. Inflammopharmacol 2005;13:1-13. [DOI: 10.1163/156856005774423953] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
54 McColl KE. Acid inhibitory medication and risk of gastric and oesophageal cancer. Gut 2006;55:1532-3. [PMID: 17047103 DOI: 10.1136/gut.2006.103283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
55 Dore MP, Graham DY. Helicobacter Pylori and Gastroesophageal Reflux Disease. In: Vela MF, Richter JE, Pandolfino JE, editors. Practical Manual of Gastroesophageal Reflux Disease. Oxford: John Wiley & Sons, Ltd; 2013. pp. 267-85. [DOI: 10.1002/9781118444788.ch16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Jakobs R, Riemann JF. cagA-positive Helicobacter pylori strains and gastro-oesophageal reflux disease: still puzzling? European Journal of Gastroenterology & Hepatology 2004;16:635-7. [DOI: 10.1097/01.meg.0000108354.41221.3e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
57 Mahdi BM. The relationship between helicobacter pylori infection and gastro-esophageal reflux disease. N Am J Med Sci 2011;3:142-5. [PMID: 22540080 DOI: 10.4297/najms.2011.3142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12(3): 354-362 [PMID: 16489633 DOI: 10.3748/wjg.v12.i3.354] [Cited by in CrossRef: 1071] [Cited by in F6Publishing: 975] [Article Influence: 66.9] [Reference Citation Analysis]
59 Degiovani M, Ribas CAPM, Czeczko NG, Parada AA, Fronchetti JA, Malafaia O. IS THERE A RELATION BETWEEN HELYBACTER PYLORI AND INTESTINAL METAPLASIA IN SHORT COLUMN EPITELIZATION UP TO 10 MM IN THE DISTAL ESOPHAGUS? Arq Bras Cir Dig 2019;32:e1480. [PMID: 31859933 DOI: 10.1590/0102-672020190001e1480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Raphael KL, Walsh P, Benias PC. Innovations in Endoscopic Therapy for Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am 2020;30:291-307. [PMID: 32146947 DOI: 10.1016/j.giec.2019.12.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Singendonk M, Goudswaard E, Langendam M, van Wijk M, van Etten-jamaludin F, Benninga M, Tabbers M. Prevalence of Gastroesophageal Reflux Disease Symptoms in Infants and Children: A Systematic Review. Journal of Pediatric Gastroenterology & Nutrition 2019;68:811-7. [DOI: 10.1097/mpg.0000000000002280] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 5.7] [Reference Citation Analysis]
62 Wu JC, Cheung CM, Wong VW, Sung JJ. Distinct Clinical Characteristics Between Patients With Nonerosive Reflux Disease and Those With Reflux Esophagitis. Clinical Gastroenterology and Hepatology 2007;5:690-5. [DOI: 10.1016/j.cgh.2007.02.023] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 4.9] [Reference Citation Analysis]
63 Lee YC, Liou JM, Wu MS, Wu CY, Lin JT. Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone. Therap Adv Gastroenterol. 2008;1:111-120. [PMID: 21180520 DOI: 10.1177/1756283x08094880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
64 Pilotto A, Perri F, Leandro G, Franceschi M. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study. Gerontology. 2006;52:99-106. [PMID: 16508317 DOI: 10.1159/000090955] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
65 Sánchez Delgado J, García-iglesias P, Titó L, Puig I, Planella M, Gené E, Saló J, Martínez-cerezo F, Molina-infante J, Gisbert JP, Calvet X. Actualización en el manejo de la infección por Helicobacter pylori. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología 2018;41:272-80. [DOI: 10.1016/j.gastrohep.2017.12.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
66 Siao D, Somsouk M. Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Intern Med. 2014;29:520-528. [PMID: 24065381 DOI: 10.1007/s11606-013-2630-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
67 Vega KJ, Chisholm S, Jamal MM. Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites. World J Gastroenterol 2009; 15(23): 2878-2881 [PMID: 19533809 DOI: 10.3748/wjg.15.2878] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
68 Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, Wang HP, Wu MS, Chen TH. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut. 2009;58:174-181. [PMID: 18936105 DOI: 10.1136/gut.2008.162305] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
69 Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005;21 Suppl 2:10-18. [PMID: 15943841 DOI: 10.1111/j.1365-2036.2005.02468.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
70 Moon CM, Jung SA, Kim SE, Song HJ, Jung Y, Ye BD, Cheon JH, Kim YS, Kim YH, Kim JS, Han DS; CONNECT study group. Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study. PLoS One. 2015;10:e0144390. [PMID: 26647084 DOI: 10.1371/journal.pone.0144390] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
71 Miwa H, Oshima T, Tomita T, Kim Y, Hori K, Matsumoto T. Gastro-esophageal reflux disease: the recent trend in Japan. Clin J Gastroenterol 2008;1:133-8. [DOI: 10.1007/s12328-008-0039-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
72 Rajendra S. Barrett’s oesophagus in Asians - are ethnic differences due to genes or the environment?: Review: Barrett’s oesophagus in Asians. Journal of Internal Medicine 2011;270:421-7. [DOI: 10.1111/j.1365-2796.2011.02400.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
73 Oryu M, Mori H, Kobara H, Nishiyama N, Fujihara S, Kobayashi M, Yasuda M, Masaki T. Differences in the Characteristics of Barrett's Esophagus and Barrett's Adenocarcinoma between the United States and Japan. ISRN Gastroenterol 2013;2013:840690. [PMID: 23606979 DOI: 10.1155/2013/840690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Ferrández A, Benito R, Arenas J, García-González MA, Sopeña F, Alcedo J, Ortego J, Sainz R, Lanas A. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate. BMC Gastroenterol 2006;6:7. [PMID: 16483364 DOI: 10.1186/1471-230X-6-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
75 Pourmasoumi M, Najafgholizadeh A, Hadi A, Mansour-ghanaei F, Joukar F. The effect of synbiotics in improving Helicobacter pylori eradication: A systematic review and meta-analysis. Complementary Therapies in Medicine 2019;43:36-43. [DOI: 10.1016/j.ctim.2019.01.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
76 de Wit NJ, de Boer WA, Geldof H, Hazelhoff B, Bergmans P, Tytgat GNJ, Smout AJPM. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?: TREATMENT OF GERD WITH RABEPRAZOLE. Alimentary Pharmacology & Therapeutics 2004;20:451-8. [DOI: 10.1111/j.1365-2036.2004.02096.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
77 Fallone CA, Barkun AN, Mayrand S, Wakil G, Friedman G, Szilagyi A, Wheeler C, Ross D. There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori. Aliment Pharmacol Ther 2004;20:761-8. [PMID: 15379836 DOI: 10.1111/j.1365-2036.2004.02171.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
78 Hung LJ, Hsu PI, Yang CY, Wang EM, Lai KH. Prevalence of gastroesophageal reflux disease in a general population in Taiwan. J Gastroenterol Hepatol. 2011;26:1164-1168. [PMID: 21517967 DOI: 10.1111/j.1440-1746.2011.06750.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
79 Otero LL, Ruiz VE, Perez Perez GI. Helicobacter pylori: The balance between a role as colonizer and pathogen. Best Practice & Research Clinical Gastroenterology 2014;28:1017-29. [DOI: 10.1016/j.bpg.2014.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
80 Liu L, Gao H, Wang H, Yu W, Zhu K, Zhang Y, Guo J. Comparison of Esophageal Function Tests to Investigate the Effect of Helicobacter Pylori Infection on Gastroesophageal Reflux Disease (GERD). Med Sci Monit. 2018;24:4791-4797. [PMID: 29992917 DOI: 10.12659/msm.908051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
81 Scholten T. Long-term management of gastroesophageal reflux disease with pantoprazole. Ther Clin Risk Manag 2007;3:231-43. [PMID: 18360632 DOI: 10.2147/tcrm.2007.3.2.231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
82 Oridate N, Takeda H, Asaka M, Nishizawa N, Mesuda Y, Mori M, Furuta Y, Fukuda S. Acid-suppression therapy offers varied laryngopharyngeal and esophageal symptom relief in laryngopharyngeal reflux patients. Dig Dis Sci. 2008;53:2033-2038. [PMID: 18080197 DOI: 10.1007/s10620-007-0114-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
83 Johansson J, Håkansson HO, Mellblom L, Kempas A, Johansson KE, Granath F, Nyrén O. Risk factors for Barrett's oesophagus: a population-based approach. Scand J Gastroenterol 2007;42:148-56. [PMID: 17327933 DOI: 10.1080/00365520600881037] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
84 You JHS, Wong P, Wu JCY. Cost-effectiveness of Helicobacter pylori “test and treat” for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: A Markov model analysis. Scandinavian Journal of Gastroenterology 2009;41:21-9. [DOI: 10.1080/00365520510023873] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
85 Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol. 2010;105:1007-1013; quiz 1006, 1014. [PMID: 20087334 DOI: 10.1038/ajg.2009.734] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
86 Holmes KP, Fang JC, Jackson BR. Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern. BMC Health Serv Res 2010;10:344. [PMID: 21176158 DOI: 10.1186/1472-6963-10-344] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
87 Eusebi LH, Ratnakumaran R, Bazzoli F, Ford AC. Prevalence of Dyspepsia in Individuals With Gastroesophageal Reflux–Type Symptoms in the Community: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2018;16:39-48.e1. [DOI: 10.1016/j.cgh.2017.07.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
88 Mangili A. Gastric and Esophageal Emergencies. Emergency Medicine Clinics of North America 2011;29:273-91. [DOI: 10.1016/j.emc.2011.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Monajemzadeh M, Abbasi A, Tanzifi P, Taba Taba Vakili S, Irani H, Kashi L. The Relation between Helicobacter pylori Infection and Acute Bacterial Diarrhea in Children. Int J Pediatr 2014;2014:191643. [PMID: 24696690 DOI: 10.1155/2014/191643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
90 Issing WJ, Karkos PD. Atypical manifestations of gastro-oesophageal reflux. J R Soc Med 2003;96:477-80. [PMID: 14519722 DOI: 10.1258/jrsm.96.10.477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
91 McColl KEHelicobacter pylori infection and long term proton pump inhibitor therapy. Gut. 2004;53:5-7. [PMID: 14684566 DOI: 10.1136/gut.53.1.5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
92 Axon ATR. Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis: PERSONAL VIEW: H. PYLORI AND GERD. Alimentary Pharmacology & Therapeutics 2004;19:253-61. [DOI: 10.1111/j.1365-2036.2004.01847.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
93 McColl KE. Helicobacter pylori and oesophageal cancer--not always protective. Gut. 2007;56:457-459. [PMID: 17369378 DOI: 10.1136/gut.2006.111385] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
94 Carvalho MA, Machado NC, Ortolan EV, Rodrigues MA. Upper gastrointestinal histopathological findings in children and adolescents with nonulcer dyspepsia with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2012;55:523-529. [PMID: 22684348 DOI: 10.1097/mpg.0b013e3182618136] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
95 Nagy P, Johansson S, Molloy-Bland M. Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathog. 2016;8:8. [PMID: 26981156 DOI: 10.1186/s13099-016-0091-7] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 13.2] [Reference Citation Analysis]
96 Cheung TK, Lim PW, Wong BC. Noncardiac chest pain--an Asia-Pacific survey on the views of primary care physicians. Dig Dis Sci 2007;52:3043-8. [PMID: 17436083 DOI: 10.1007/s10620-007-9764-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
97 Lee HS, Jeon SW. Barrett esophagus in Asia: same disease with different pattern. Clin Endosc. 2014;47:15-22. [PMID: 24570879 DOI: 10.5946/ce.2014.47.1.15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
98 Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan J. A comparison of the clinical, demographic and psychiatric profiles among patients with erosive and non-erosive reflux disease in a multi-ethnic Asian country. World J Gastroenterol 2005; 11(23): 3558-3561 [PMID: 15962374 DOI: 10.3748/wjg.v11.i23.3558] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
99 Delaney B, McColl K. Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;22 Suppl 1:32-40. [PMID: 16042657 DOI: 10.1111/j.1365-2036.2005.02607.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
100 Vasapolli R, Malfertheiner P, Kandulski A. Helicobacter pylori and non-malignant upper gastrointestinal diseases. Helicobacter 2016;21 Suppl 1:30-3. [PMID: 27531536 DOI: 10.1111/hel.12337] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
101 Jessurun J. Helicobacter pylori: an evolutionary perspective. Histopathology 2021;78:39-47. [PMID: 33382492 DOI: 10.1111/his.14245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Moayyedi P, Hunt RH. Helicobacter pylori public health implications. Helicobacter 2004;9 Suppl 1:67-72. [PMID: 15347308 DOI: 10.1111/j.1083-4389.2004.00250.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
103 Wang SE, Kendall BJ, Hodge AM, Dixon-Suen SC, Dashti SG, Makalic E, Williamson EM, Thomas RJS, Giles GG, English DR. Demographic and lifestyle risk factors for gastroesophageal reflux disease and Barrett's esophagus in Australia. Dis Esophagus 2021:doab058. [PMID: 34409990 DOI: 10.1093/dote/doab058] [Reference Citation Analysis]
104 Dent J, Becher A, Sung J, Zou D, Agréus L, Bazzoli F. Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys. Clin Gastroenterol Hepatol 2012;10:863-873.e3. [PMID: 22401904 DOI: 10.1016/j.cgh.2012.02.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
105 Kyburz A, Müller A. Helicobacter pylori and Extragastric Diseases. In: Tegtmeyer N, Backert S, editors. Molecular Pathogenesis and Signal Transduction by Helicobacter pylori. Cham: Springer International Publishing; 2017. pp. 325-47. [DOI: 10.1007/978-3-319-50520-6_14] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
106 Robins G, Crabtree JE, Bailey A, Forman D; EUROGAST Study Group. International variation in Helicobacter pylori infection and rates of oesophageal cancer. Eur J Cancer 2008;44:726-32. [PMID: 18280140 DOI: 10.1016/j.ejca.2008.01.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
107 Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40:275-285. [PMID: 15932168 DOI: 10.1080/00365520510011579] [Cited by in Crossref: 286] [Cited by in F6Publishing: 249] [Article Influence: 16.8] [Reference Citation Analysis]
108 Kronsteiner B, Bassaganya-Riera J, Philipson C, Viladomiu M, Carbo A, Abedi V, Hontecillas R. Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis. Gut Microbes 2016;7:3-21. [PMID: 26939848 DOI: 10.1080/19490976.2015.1116673] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
109 Koivurova O, Karhukorpi JMJ, Joensuu ET, Koistinen PO, Valtonen JM, Karttunen TJ, Niemelä SE, Karttunen RA. IL‐1 RN 2/2 genotype and simultaneous carriage of genotypes IL‐1 RN 2/2 and IL‐1β‐511 T/T associated with oesophagitis in Helicobacter pylori‐negative patients. Scandinavian Journal of Gastroenterology 2009;38:1217-22. [DOI: 10.1080/00365520310006504] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
110 Luther J, Owyang SY, Takeuchi T, Cole TS, Zhang M, Liu M, Erb-Downward J, Rubenstein JH, Chen CC, Pierzchala AV. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut. 2011;60:1479-1486. [PMID: 21471567 DOI: 10.1136/gut.2010.220087] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
111 Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, Quesenberry C, Buffler P, Parsonnet J. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008;13:352-360. [PMID: 19250510 DOI: 10.1111/j.1523-5378.2008.00624.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
112 Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agréus L, Jablonowski H, Tafalla M. Consultation rates and characteristics of gastro-oesophageal reflux disease in primary care: A European observational study. European Journal of General Practice 2009;15:154-60. [DOI: 10.3109/13814780903260764a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
113 Collins J, Ali-ibrahim A, Smoot DT. Antibiotic Therapy for Helicobacter pylori. Medical Clinics of North America 2006;90:1125-40. [DOI: 10.1016/j.mcna.2006.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
114 Oikawa T, Asano N, Imatani A, Ohyauchi M, Fushiya J, Kondo Y, Abe Y, Koike T, Iijima K, Shimosegawa T. Gene polymorphisms of NOD1 and interleukin-8 influence the susceptibility to erosive esophagitis in Helicobacter pylori infected Japanese population. Hum Immunol 2012;73:1184-9. [PMID: 22902391 DOI: 10.1016/j.humimm.2012.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
115 Tzouvelekis A, Kaminski N. Epigenetics in idiopathic pulmonary fibrosis. Biochem Cell Biol 2015;93:159-70. [PMID: 25659821 DOI: 10.1139/bcb-2014-0126] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
116 Oridate N, Takeda H, Yamamoto J, Asaka M, Mesuda Y, Nishizawa N, Mori M, Furuta Y, Fukuda S. Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms. Laryngoscope. 2006;116:547-553. [PMID: 16585857 DOI: 10.1097/01.mlg.0000201907.24514.6a] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
117 El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, Crowe SE, Elfant A, Haas T, Hapke RJ, Graham DY. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol 2018;16:992-1002.e6. [PMID: 29559361 DOI: 10.1016/j.cgh.2018.03.013] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 17.8] [Reference Citation Analysis]
118 Issing WJ, Karkos PD. Atypical Manifestations of Gastro-Oesophageal Reflux. J R Soc Med 2017;96:477-80. [DOI: 10.1177/014107680309601002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
119 Can ME, Kaplan FE, Uzel MM, Kiziltoprak H, Ergun MC, Koc M, Simsek G. The association of Helicobacter pylori with choroidal and retinal nerve fiber layer thickness. Int Ophthalmol 2018;38:1915-22. [PMID: 28780617 DOI: 10.1007/s10792-017-0677-1] [Reference Citation Analysis]
120 Coelho LGV, Marinho JR, Genta R, Ribeiro LT, Passos MDCF, Zaterka S, Assumpção PP, Barbosa AJA, Barbuti R, Braga LL, Breyer H, Carvalhaes A, Chinzon D, Cury M, Domingues G, Jorge JL, Maguilnik I, Marinho FP, Moraes-filho JPD, Parente JML, Paula-e-silva CMD, Pedrazzoli-júnior J, Ramos AFP, Seidler H, Spinelli JN, Zir JV. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arq Gastroenterol 2018;55:97-121. [DOI: 10.1590/s0004-2803.201800000-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
121 Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469-476. [PMID: 22221289 DOI: 10.1111/j.1365-2036.2011.04969.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
122 Baldi F. Key points in the management of gastroesophageal reflux disease. Curr Gastroenterol Rep 2007;9:1-2. [PMID: 17335671 DOI: 10.1007/s11894-008-0014-y] [Reference Citation Analysis]
123 Xie SH, Lagergren J. Risk factors for oesophageal cancer. Best Pract Res Clin Gastroenterol. 2018;36-37:3-8. [PMID: 30551854 DOI: 10.1016/j.bpg.2018.11.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
124 Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006;367:2086-2100. [PMID: 16798392 DOI: 10.1016/s0140-6736(06)68932-0] [Cited by in Crossref: 270] [Cited by in F6Publishing: 93] [Article Influence: 16.9] [Reference Citation Analysis]
125 Hassan AA, Youssef AI, Ghazal AA, Sheta MI, Diwedar NL, Hafez EM, Tabll AA, Elbendary EY. Blood group antigen-Binding Adhesion2 (BabA2) gene in gastric tissue biopsies as a diagnostic biomarker for Helicobacter pylori infection. Hum Antibodies 2019. [PMID: 30909206 DOI: 10.3233/HAB-190372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
126 Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354-362. [PMID: 16489633 DOI: 10.5732/cjc.011.10122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
127 Zou D, He J, Ma X, Chen J, Gong Y, Man X, Gao L, Wang R, Zhao Y, Yan X. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC). Scand J Gastroenterol. 2011;46:133-141. [PMID: 20955088 DOI: 10.3109/00365521.2010.521888] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
128 Smolka AJ, Schubert ML. Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease. Curr Top Microbiol Immunol 2017;400:227-52. [PMID: 28124156 DOI: 10.1007/978-3-319-50520-6_10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
129 Axon A. Helicobacter pylori: What Do We Still Need to Know? Journal of Clinical Gastroenterology 2006;40:15-9. [DOI: 10.1097/01.mcg.0000190752.48621.fa] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
130 Tack J. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease. Curr Opin Gastroenterol. 2005;21:454-460. [PMID: 15930988 DOI: 10.1097/01.mog.0000166657.09968.4b] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
131 Banning M. Helicobacter pylori-induced gastritis: pathophysiology, assessment and treatment. Nurse Prescribing 2004;2:219-23. [DOI: 10.12968/npre.2004.2.5.16091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Jie W, Qinghong X, Zhitao C. Association of Helicobacter pylori infection with gastroesophageal reflux disease. J Int Med Res 2019;47:748-53. [PMID: 30453813 DOI: 10.1177/0300060518809871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Herndon B, Quinn T, Wasson N, Nzabi M, Molteni A. Urease and Helicobacter spp. antigens in pulmonary granuloma. J Comp Pathol. 2013;148:266-277. [PMID: 22901429 DOI: 10.1016/j.jcpa.2012.06.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
134 Abdul-Razzak KK, Bani-Hani KE. Increased prevalence of Helicobacter pylori infection in gastric cardia of patients with reflux esophagitis: a study from Jordan. J Dig Dis 2007;8:203-6. [PMID: 17970877 DOI: 10.1111/j.1751-2980.2007.00306.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
135 Sugimoto M, Murata M, Iwata E, Nagata N, Itoi T, Kawai T. Risk of Reflux-Related Symptoms and Reflux Esophagitis after Helicobacter pylori Eradication Treatment in the Japanese Population. J Clin Med 2021;10:1434. [PMID: 33916067 DOI: 10.3390/jcm10071434] [Reference Citation Analysis]
136 Roman S, Pandolfino JE. Environmental - lifestyle related factors. Best Pract Res Clin Gastroenterol. 2010;24:847-859. [PMID: 21126698 DOI: 10.1016/j.bpg.2010.09.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
137 Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology. 2010;139:1894-1901. [PMID: 20727889 DOI: 10.1053/j.gastro.2010.08.018] [Cited by in Crossref: 133] [Cited by in F6Publishing: 123] [Article Influence: 11.1] [Reference Citation Analysis]
138 Ylitalo R. Helicobacter pylori infection and its correlation to extraesophageal and esophageal reflux in contact granuloma patients. Logopedics Phoniatrics Vocology 2009;31:57-60. [DOI: 10.1080/14015430500488096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
139 El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871-880. [PMID: 23853213 DOI: 10.1136/gutjnl-2012-304269] [Cited by in Crossref: 819] [Cited by in F6Publishing: 628] [Article Influence: 91.0] [Reference Citation Analysis]
140 Gatopoulou A, Mimidis K, Giatromanolaki A, Polichronidis A, Lirantzopoulos N, Sivridis E, Minopoulos G. Impact of Helicobacter pylori infection on histological changes in non-erosive reflux disease. World J Gastroenterol 2004; 10(8): 1180-1182 [PMID: 15069722 DOI: 10.3748/wjg.v10.i8.1180] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
141 Ashktorab H, Entezari O, Nouraie M, Dowlati E, Frederick W, Woods A, Lee E, Brim H, Smoot DT, Ghadyari F. Helicobacter pylori protection against reflux esophagitis. Dig Dis Sci. 2012;57:2924-2928. [PMID: 23010740 DOI: 10.1007/s10620-012-2349-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
142 Chung SJ, Lim SH, Choi J, Kim D, Kim YS, Park MJ, Yim JY, Kim JS, Cho SH, Jung HC, Song IS. Helicobacter pylori Serology Inversely Correlated With the Risk and Severity of Reflux Esophagitis in Helicobacter pylori Endemic Area: A Matched Case-Control Study of 5,616 Health Check-Up Koreans. J Neurogastroenterol Motil. 2011;17:267-273. [PMID: 21860818 DOI: 10.5056/jnm.2011.17.3.267] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
143 Tanaka E, Kamitsuji S, Inoue E, Yamada T, Nakajima A, Takeuchi E, Yanagisawa A, Misaka R, Shigemoto M, Yamashita K, Imamura T, Hara M, Tomatsu T, Saito T, Lauren G, Triadafilopoulos G, Kamatani N, Singh G, Yamanaka H. Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis. Modern Rheumatology 2014;17:228-34. [DOI: 10.3109/s10165-007-0570-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
144 Raftopoulos SC, Kumarasinghe P, de Boer B, Iacobelli J, Kontorinis N, Fermoyle S, Olynyk J, Forrest C, Ee HC, Yusoff IF. Gastric intraepithelial neoplasia in a Western population: . European Journal of Gastroenterology & Hepatology 2012;24:48-54. [DOI: 10.1097/meg.0b013e32834dc1bb] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
145 Lee Y, Lin J, Chen TH, Wu M. Is Eradication of Helicobacter pylori the Feasible Way to Prevent Gastric Cancer? New Evidence and Progress, but Still a Long Way to Go. Journal of the Formosan Medical Association 2008;107:591-9. [DOI: 10.1016/s0929-6646(08)60176-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
146 Lai CH, Poon SK, Chen YC, Chang CS, Wang WC. Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease. Helicobacter 2005;10:577-85. [PMID: 16302983 DOI: 10.1111/j.1523-5378.2005.00363.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
147 Kandulski A, Malfertheiner P. Helicobacter pylori and gastroesophageal reflux disease: . Current Opinion in Gastroenterology 2014;30:402-7. [DOI: 10.1097/mog.0000000000000085] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
148 Di Mario F, Goni E. Gastric acid secretion: Changes during a century. Best Practice & Research Clinical Gastroenterology 2014;28:953-65. [DOI: 10.1016/j.bpg.2014.10.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
149 Raghunath AS, Hungin APS, Mason J, Jackson W. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors. Alimentary Pharmacology & Therapeutics 2009;29:431-9. [DOI: 10.1111/j.1365-2036.2008.03897.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
150 Lim LG, Ho KY. Gastroesophageal reflux disease at the turn of millenniumWorld J Gastroenterol 2003; 9(10): 2135-2136 [PMID: 14562363 DOI: 10.3748/wjg.v9.i10.2135] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
151 Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, Ben-Shlomo Y. Helicobacter pylori eradication for Parkinson's disease. Cochrane Database Syst Rev 2011;:CD008453. [PMID: 22071847 DOI: 10.1002/14651858.CD008453.pub2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
152 Zou D, He J, Ma X, Liu W, Chen J, Shi X, Ye P, Gong Y, Zhao Y, Wang R, Yan X, Man X, Gao L, Dent J, Sung J, Wernersson B, Johansson S, Li Z. Helicobacter pylori infection and gastritis: The Systematic Investigation of gastrointestinaL diseases in China (SILC). J Gastroenterol Hepatol. 2011;26:908-915. [PMID: 21198827 DOI: 10.1111/j.1440-1746.2010.06608.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
153 Sugimoto M, Murata M, Mizuno H, Iwata E, Nagata N, Itoi T, Kawai T. Endoscopic Reflux Esophagitis and Reflux-Related Symptoms after Helicobacter pylori Eradication Therapy: Meta-Analysis. J Clin Med 2020;9:E3007. [PMID: 32961949 DOI: 10.3390/jcm9093007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
154 Ried K, Travica N, Dorairaj R, Sali A. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutr Res 2020;76:37-51. [PMID: 32151878 DOI: 10.1016/j.nutres.2020.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Masjedizadeh R, Hajiani E, MoezArdalan K, Samie S, Ehsani-Ardakani MJ, Daneshmand A, Zali MR. H pylori infection and reflux oesophagitis: A case-control study. World J Gastroenterol 2006; 12(35): 5658-5662 [PMID: 17007018 DOI: 10.3748/wjg.v12.i35.5658] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
156 Iijima K, Koike T, Abe Y, Ohara S, Nakaya N, Shimosegawa T. Time series analysis of gastric acid secretion over a 20-year period in normal Japanese men. J Gastroenterol 2015;50:853-61. [DOI: 10.1007/s00535-014-1031-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
157 Malfertheiner P. Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease. Gut 2004;53:312-3. [PMID: 14724171 DOI: 10.1136/gut.2003.019836] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
158 Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2012;47:129-135. [PMID: 22229305 DOI: 10.3109/00365521.2011.648955] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
159 El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871-880. [PMID: 23853213 DOI: 10.1136/gutjnl2012-304269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
160 Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol 2005;40:938-44. [PMID: 16261430 DOI: 10.1007/s00535-005-1677-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
161 Parente FR, Bargiggia SA, Anderloni A. Helicobacter pylori infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: A liaison dangereuse or an innocent interplay? Scandinavian Journal of Gastroenterology 2009;41:1121-5. [DOI: 10.1080/00365520600931584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
162 Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany: EPIDEMIOLOGY OF CHRONIC ATROPHIC GASTRITIS. Alimentary Pharmacology & Therapeutics 2007;26:879-87. [DOI: 10.1111/j.1365-2036.2007.03430.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
163 Fischbach LA, Graham DY, Kramer JR, Rugge M, Verstovsek G, Parente P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Kolpachi A, Gupta S, Vela MF, Velez M, Cole R, Anand B, El Serag HB. Association between Helicobacter pylori and Barrett's esophagus: a case-control study. The American journal of gastroenterology. 2014;109:357-368. [PMID: 24419485 DOI: 10.1038/ajg.2013.443] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
164 Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Arakawa T. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol 2005;100:754-8. [PMID: 15784015 DOI: 10.1111/j.1572-0241.2005.40966.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
165 Shim K, Hong SJ, Sung JK, Park KS, Kim S, Park H, Kim YS, Lim SH, Kim CH, Park MJ, Yim JY, Cho KR, Kim D, Park SJ, Jee S, Kim JI, Park JY, Song GA, Jung H, Lee YC, Kim JG, Kim JJ, Kim N, Park S, Jung HC, Chung I. Clinical Spectrum of Reflux Esophagitis Among 25,536 Koreans Who Underwent a Health Check-up: A Nationwide Multicenter Prospective, Endoscopy-based Study. Journal of Clinical Gastroenterology 2009;43:632-8. [DOI: 10.1097/mcg.0b013e3181855055] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
166 Mitchell DR, Derakhshan MH, Robertson EV, Mccoll KEL. The Role of the Acid Pocket in Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 2016;50:111-9. [DOI: 10.1097/mcg.0000000000000439] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
167 Rubenstein JH, Inadomi JM, Scheiman J, Schoenfeld P, Appelman H, Zhang M, Metko V, Kao JY. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 2014;12:239-45. [PMID: 23988686 DOI: 10.1016/j.cgh.2013.08.029] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 8.0] [Reference Citation Analysis]
168 Owyang SY, Luther J, Kao JY. Helicobacter pylori: beneficial for most? Expert Rev Gastroenterol Hepatol 2011;5:649-51. [PMID: 22017690 DOI: 10.1586/egh.11.69] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
169 Nam SY, Choi IJ, Nam BH, Park KW, Kim CG. Obesity and weight gain as risk factors for erosive oesophagitis in men. Aliment Pharmacol Ther. 2009;29:1042-1052. [PMID: 19222414 DOI: 10.1111/j.1365-2036.2009.03965.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
170 Jonaitis LV, Kiudelis G, Kupcinskas L. Characteristics of patients with erosive and nonerosive Gerd in high-Helicobacter-pylori prevalence region. Diseases of the Esophagus 2004;17:223-7. [DOI: 10.1111/j.1442-2050.2004.00412.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
171 Richter JE. The Many Manifestations of Gastroesophageal Reflux Disease: Presentation, Evaluation, and Treatment. Gastroenterology Clinics of North America 2007;36:577-99. [DOI: 10.1016/j.gtc.2007.07.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
172 Raghunath A, Hungin A, Cornford C, Featherstone V. Use of Proton Pump Inhibitors: An Exploration of the Attitudes, Knowledge and Perceptions of General Practitioners. Digestion 2005;72:212-8. [DOI: 10.1159/000089727] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
173 De Vries AC, Kuipers EJ. Review article: Helicobacter pylori eradication for the prevention of gastric cancer: REVIEW: H. PYLORI ERADICATION FOR GASTRIC CANCER PREVENTION. Alimentary Pharmacology & Therapeutics 2007;26:25-35. [DOI: 10.1111/j.1365-2036.2007.03475.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
174 Kawai T, Yamamoto K, Fukuzawa M, Yamagishi T, Yagi K, Fukuzawa M, Kataoka M, Kawakami K, Itoi T, Sakai Y, Moriyasu F, Takagi Y, Aoki T. Helicobacter pylori infection and reflux esophagitis in young and middle-aged Japanese subjects: Helicobacter pylori and reflux esophagitis. Journal of Gastroenterology and Hepatology 2010;25:S80-5. [DOI: 10.1111/j.1440-1746.2010.06228.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
175 Unal S, Karakan T, Dogan I, Cindoruk M, Dumlu S. The Influence of Helicobacter pylori Infection on the Prevalence of Endoscopic Erosive Esophagitis. Helicobacter 2006;11:556-61. [DOI: 10.1111/j.1523-5378.2006.00458.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
176 Isakov V, Malfertheiner P. Helicobacter pylori and nonmalignant diseases. Helicobacter. 2003;8 Suppl 1:36-43. [PMID: 14617216 DOI: 10.1046/j.1523-5378.2003.00169.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
177 Calleja JL, Suarez M, De Tejada AH, Navarro A. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. Dig Dis Sci. 2005;50:432-439. [PMID: 15810621 DOI: 10.1007/s10620-005-2453-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
178 Haruma K. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004;20 Suppl 8:40-4. [PMID: 15575872 DOI: 10.1111/j.1365-2036.2004.02228.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
179 Sonnenberg A, Melton SD, Genta RM. Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:39-44. [PMID: 20848539 DOI: 10.1002/ibd.21356] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
180 彭颖, 李晓波. 倍半萜内酯类治疗肠易激综合征的应用前景. 世界华人消化杂志 2017; 25(18): 1624-1632 [DOI: 10.11569/wcjd.v25.i18.1624] [Reference Citation Analysis]
181 Iijima K, Koike T, Shimosegawa T. Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? Front Microbiol 2015;6:566. [PMID: 26106373 DOI: 10.3389/fmicb.2015.00566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
182 Lee HY, Kim JW, Lee JK, Heo EY, Chung HS, Kim DK. Association between Helicobacter pylori seropositivity and mild to moderate COPD: clinical implications in an Asian country with a high prevalence of H. pylori. Int J Chron Obstruct Pulmon Dis 2016;11:2055-62. [PMID: 27621611 DOI: 10.2147/COPD.S106922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
183 Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM, Møller H, Davies EA. Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer. 2012;12:11. [PMID: 22239958 DOI: 10.1186/1471-2407-12-11] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
184 Mann R, Gajendran M, Perisetti A, Goyal H, Saligram S, Umapathy C. Advanced Endoscopic Imaging and Interventions in GERD: An Update and Future Directions. Front Med (Lausanne) 2021;8:728696. [PMID: 34912815 DOI: 10.3389/fmed.2021.728696] [Reference Citation Analysis]
185 Yalaki S, Pulat H, Ilhan A. Localization of Helicobacter pylori gastritis and the relation of existing histopathological features with reflux esophagitis. Scand J Gastroenterol 2020;55:27-33. [PMID: 31865819 DOI: 10.1080/00365521.2019.1701071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
186 Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1-15. [PMID: 17322988 DOI: 10.1007/s00535-006-1990-z] [Cited by in Crossref: 113] [Cited by in F6Publishing: 109] [Article Influence: 7.5] [Reference Citation Analysis]
187 Lien HC, Chang CS, Yeh HZ, Ko CW, Chang HY, Cheng KF, Sung FC. Increasing prevalence of erosive esophagitis among Taiwanese aged 40 years and above: a comparison between two time periods. J Clin Gastroenterol 2009;43:926-32. [PMID: 19384245 DOI: 10.1097/MCG.0b013e318191e9d5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
188 Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyrén O. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96:388-396. [PMID: 14996860 DOI: 10.1093/jnci/djh057] [Cited by in Crossref: 238] [Cited by in F6Publishing: 230] [Article Influence: 13.2] [Reference Citation Analysis]
189 Früh M, Zhou W, Zhai R, Su L, Heist RS, Wain JC, Nishioka NS, Lynch TJ, Shepherd FA, Christiani DC, Liu G. Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Br J Cancer 2008;98:689-92. [PMID: 18253117 DOI: 10.1038/sj.bjc.6604234] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
190 Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clinical gastroenterology and hepatology:. the official clinical practice journal of the American Gastroenterological Association. 2007;5:1413-1417, 1417 e1411-1412. [PMID: 17997357 DOI: 10.1016/j.cgh.2007.08.010] [Cited by in Crossref: 135] [Cited by in F6Publishing: 111] [Article Influence: 9.0] [Reference Citation Analysis]
191 Shahabi S, Rasmi Y, Jazani NH, Hassan ZM. Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol. 2008;86:175-178. [PMID: 17923849 DOI: 10.1038/sj.icb.7100119] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
192 Shah SC, Tepler A, Peek RM Jr, Colombel JF, Hirano I, Narula N. Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2019;17:2185-2198.e3. [PMID: 30659992 DOI: 10.1016/j.cgh.2019.01.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
193 Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis. 2008;40:619-626. [PMID: 18396114 DOI: 10.1016/j.dld.2008.02.026] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
194 Simán JH, Engstrand L, Berglund G, Forsgren A, Florén CH. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol 2007;42:933-40. [PMID: 17613922 DOI: 10.1080/00365520601173863] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
195 Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013;108:208-15. [PMID: 23208272 DOI: 10.1038/ajg.2012.407] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 9.2] [Reference Citation Analysis]
196 Jeong YJ, Lee DH, Choi TH, Hwang TJ, Lee BH, Nah JC, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N, Jung HC, Song IS. [Clinical analysis of recurrence rate and symptom improvement in gastro-esophageal reflux disease patients]. Korean J Gastroenterol 2010;55:100-8. [PMID: 20168056 DOI: 10.4166/kjg.2010.55.2.100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
197 Richter JE. Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease. Gut 2004;53:310-1. [PMID: 14724170 DOI: 10.1136/gut.2003.019844] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]